查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2014299

白內障手術設備市場：按產品類型、技術和最終用戶分類 - 2026-2032年全球市場預測

Cataract Surgery Devices Market by Product Type, Technology, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年白內障手術設備市場價值為 85 億美元，預計到 2026 年將成長至 91.8 億美元，複合年成長率為 8.36%，到 ​​2032 年將達到 149.3 億美元。

主要市場統計數據
基準年 2025 85億美元
預計年份：2026年 91.8億美元
預測年份 2032 149.3億美元
複合年成長率 (%) 8.36%

在臨床創新、醫療保健服務環境變化和採購要求的背景下，白內障手術器材的發展趨勢。

白內障手術器材在外科創新、人口需求和醫療服務體系發展三者交匯處佔據著至關重要的地位。過去十年，該領域已從依賴傳統的超音波乳化術和單焦點人工水晶體發展到如今擁有更多選擇，旨在改善屈光效果、縮短恢復時間並創造更安全的手術環境。這些進步得益於成像技術、雷射精度、人工水晶體設計以及旨在保護眼組織和最佳化術中操作的耗材等方面的同步發展。

高精度雷射、多樣化的人工水晶體結構和分散式醫療服務如何重新定義臨床實務和供應商策略。

在白內障手術設備領域，正在發生多項變革性變化，這些變化正在重塑臨床方案、供應商策略和投資重點。首先，精準引導的飛秒雷射系統正在改變手動操作的角色，它能夠實現高度可重複的囊膜切開術和精準的弧形切口，進而影響高階人工水晶體的選擇以及對屈光矯正效果的預期。同時，人工水晶體的設計也從單焦點光學結構向景深擴展、多焦點、散光矯正和高度非球面等多種結構發展，從而擴大了目標患者群體，並引發了關於高階醫療服務報銷問題的更多討論。

檢驗2025 年美國關稅措施對營運和採購的影響，以及這些措施對醫療設備採購和臨床部署的連鎖反應。

美國近期針對2025年實施的關稅措施以及更廣泛的貿易政策環境，對白內障手術醫療設備的供應鏈產生了顯著的連鎖反應，促使製造商和醫療服務提供者重新評估籌資策略和成本結構。由於許多醫療設備和關鍵零件的生產地點分散，進口關稅的增加引發了一系列連鎖反應。一些供應商暫時自行承擔成本以維持市場進入，另一些供應商則將採購轉向國內或免稅供應商，還有一些供應商加快了關鍵子組件的本地化生產。因此，採購計畫和供應商談判中現在都加入了更明確的緊急條款和短期風險評估。

詳細的細分分析顯示產品類型、技術工作流程和醫療保健環境如何決定部署模式、培訓需求和採購優先順序。

關鍵的細分洞察揭示了產品設計、手術技術和終端用戶環境如何共同影響白內障手術設備的採用模式和投資重點。首先，從產品類型檢驗，產品線呈現連續性，涵蓋了從飛秒雷射系統等高價平台到耗材和功能主機等各個方面。人工水晶體在這一頻譜中扮演著核心角色，並進一步細分為：用於最佳化影像品質的非球面設計、用於擴大功能視野的景深晶狀體、仍然是實用預設選擇的單焦點晶狀體、旨在擺脫眼鏡的多焦點解決方案以及用於散光鏡片的散光矯正晶狀體。每個子類別都提出了不同的臨床訓練要求，並影響術後患者滿意度指標。

美洲、歐洲、中東和非洲以及亞太地區在報銷模式、手術量和基礎設施方面的區域差異如何影響醫療設備策略？

在全球白內障生態系中，區域趨勢仍是決定醫療設備分銷策略和商業化方式的主要因素。在美洲，私人保險公司的積極參與，以及廣泛的門診手術中心網路，催生了對具備高效處理、可預測結果和完善售後服務的醫療設備的需求。同時，美洲的醫療機構通常要求醫療器材能夠相容於整合平台，並提供清晰的臨床和經濟論證，以支持其資本投資決策。在歐洲、中東和非洲，法規環境和報銷模式因地區而異。雖然歐洲部分地區正在快速採用高階晶體和雷射平台，但其他市場則優先考慮成本效益和公共採購管道。在這些地區，集中採購機制和國家臨床指引對醫療器材的推廣應用時間有顯著的影響。

成熟平台營運商、鏡片創新者和軟體顛覆者之間的競爭動態和策略行動，塑造了臨床應用和商業性競爭力。

白內障治療設備領域的企業級發展趨勢呈現出多元化的特點，既有成熟的平台供應商，也有專注於軟體驅動的手術規劃和耗材最佳化的敏捷型新興參與企業。傳統上提供全平台解決方案的成熟企業，利用其現有基礎設施，透過模組化升級、服務合約和培訓包提升銷售方式，深化與臨床機構的合作關係，並確保持續的收入來源。同時，專業的人工水晶體開發者則憑藉光學工程、先進材料科學以及臨床證據，在目標患者群體中展現出顯著的屈光優勢，從而實現差異化競爭。

為加速技術採用、確保採購優勢、加強供應鏈和臨床支援能力提供切實可行的策略建議。

對於致力於將洞察轉化為實際成果的產業領導者而言，一系列切實可行的建議將加速臨床應用，增強供應鏈韌性，並最佳化商業性定位。首先，透過優先考慮能夠減少術中變異性、改善患者報告結果並融入現有手術流程的功能，使產品開發與檢驗的臨床需求保持一致。這將使製造商能夠更清晰地向外科醫生和採購委員會傳達其價值提案。其次，要認知到單例手術總成本和耗材物流是採購決策的關鍵因素，並建立彈性價格設定和服務模式，以適應門診手術中心、醫院和專科診所的經濟特徵。

調查方法，將對臨床醫生和採購負責人的初步調查與二手證據的整合以及嚴格的交叉檢驗程序相結合。

本報告的調查方法結合了系統性的初步研究和二手證據的整合，以確保得出可靠且可操作的結論。初步調查方法包括對執業眼科醫師、醫院和門診手術中心的採購經理以及負責平台整合的設備工程師進行結構化訪談。此外，還對大型手術中心進行了現場考察，並諮詢了監管專家，以檢驗設備的批准狀態和上市後要求。這些資訊來源的數據與同行評審文獻、臨床結果註冊研究和醫療設備附加檔進行了交叉比對，以檢驗技術聲明和性能差異。

整合臨床創新、營運適應性和供應鏈韌性，以確保白內障治療的永續應用和競爭地位。

總之，白內障手術醫療設備正處於一個轉折點，技術創新、醫療服務分散化和地緣政治因素的共同作用，正在影響臨床實踐和商業策略。高精度雷射、先進的人工水晶體光學技術和數位化手術規劃正在拓展患者可獲得的治療效果範圍，而門診治療模式的轉變則凸顯了處理能力、器械相容性和耗材物流的重要性。同時，貿易政策趨勢也凸顯了全球供應鏈的脆弱性以及本地生產和彈性採購安排的策略價值。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 白內障手術設備市場：依產品類型分類

  • 飛秒雷射系統
  • 人工水晶體
    • 非人工水晶體
    • 景深擴展型人工水​​晶體
    • 單焦點人工水晶體
    • 多焦點人工水晶體
    • 散光人工水晶體
  • 眼用黏彈性裝置
  • 超音波超音波乳化裝置
  • 外科耗材

第9章 白內障手術設備市場：依技術分類

  • 囊外白內障摘除術
  • 飛秒雷射輔助
    • 弧形切口
    • 關節囊切開術
    • 晶狀體碎裂
  • 手作小切口法
  • 法科姆

第10章：白內障手術設備市場：依最終用戶分類

  • 門診手術中心
  • 眼科研究所
  • 醫院
  • 眼科診所

第11章 白內障手術設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章 白內障手術設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 白內障手術設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章：美國白內障手術設備市場

第15章 中國白內障手術設備市場

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Alcon, Inc.
  • Bausch & Lomb Incorporated
  • Carl Zeiss Meditec AG
  • Essilor International SA
  • HAAG-Streit Holding AG
  • HOYA Surgical Optics, Inc.
  • Johnson & Johnson Vision Care, Inc.
  • Lenstec, Inc.
  • NIDEK Co., Ltd.
  • PhysIOL SA
  • Rayner Intraocular Lenses Limited
  • STAAR Surgical Company
  • Topcon Corporation
  • Ziemer Ophthalmic Systems AG
Product Code: MRR-433AB1DC28B7

The Cataract Surgery Devices Market was valued at USD 8.50 billion in 2025 and is projected to grow to USD 9.18 billion in 2026, with a CAGR of 8.36%, reaching USD 14.93 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 8.50 billion
Estimated Year [2026] USD 9.18 billion
Forecast Year [2032] USD 14.93 billion
CAGR (%) 8.36%

Framing the evolving cataract surgery device landscape in the context of clinical innovation, care setting shifts, and procurement imperatives

Cataract surgery devices occupy a pivotal position at the intersection of surgical innovation, demographic need, and healthcare delivery evolution. Over the past decade the field has advanced from reliance on conventional phacoemulsification and monofocal lenses toward a more diverse set of options that aim to improve refractive outcomes, reduce recovery times, and expand the settings in which procedures can be safely performed. These advances have been driven by parallel progress in imaging, laser precision, intraocular lens design, and consumables engineered to preserve ocular tissue and optimize intraoperative handling.

Consequently, clinical teams, procurement leaders, and device manufacturers are confronting a landscape that rewards interoperability, predictable supply chains, and a clear value proposition tied to clinical outcomes. As care pathways migrate from centralized hospitals to ambulatory surgery centers and specialty eye clinics, device selection increasingly reflects procedural throughput, compatibility with existing platforms, and support for emerging refractive technologies. In this context, a careful synthesis of device capabilities, regulatory trajectories, and end-user preferences is essential to inform purchasing strategies, clinical adoption, and product development roadmaps.

How precision lasers, diversified intraocular lens architectures, and care delivery decentralization are redefining clinical practice and supplier strategy

The cataract surgery device landscape is undergoing several transformative shifts that are reshaping clinical protocols, vendor strategies, and investment priorities. First, precision-guided femtosecond laser systems are altering the role of manual maneuvers by enabling more reproducible capsulotomies and targeted arcuate incisions, which in turn influence the selection of premium intraocular lenses and the expectation of refractive outcomes. In parallel, intraocular lens design has diversified beyond monofocal optics to include extended depth of focus, multifocal, toric, and advanced aspheric profiles, thereby broadening the patient populations and reimbursement conversations around premium care.

Simultaneously, the operational footprint of cataract care is shifting toward ambulatory surgery centers and high-volume ophthalmology clinics where throughput and device compatibility matter as much as instrument performance. This decentralization encourages device makers to prioritize modular systems, streamlined consumable logistics, and training packages that reduce variability in surgical results. Finally, digital integration-ranging from perioperative imaging to surgical planning software and interoperability with electronic health records-is emerging as a differentiator. Taken together, these shifts favor suppliers who can demonstrate clinical advantage, economic clarity, and an ability to integrate seamlessly into diverse care pathways.

Examining the operational and procurement consequences of U.S. tariff measures in 2025 and their implications for device sourcing and clinical adoption

Recent tariff actions and the broader trade policy environment in the United States in 2025 have created material reverberations across supply chains for cataract surgery devices, prompting manufacturers and providers to reassess sourcing strategies and cost structures. Because many devices and key components are manufactured across multiple geographies, incremental import levies have initiated a cascade of responses: some suppliers absorbed costs temporarily to preserve market access, others shifted procurement toward domestic or tariff-exempt suppliers, and a subset accelerated localization of critical subassemblies. As a result, purchasing timelines and vendor negotiations incorporated more explicit contingency clauses and near-term risk assessments.

Beyond direct cost implications, tariffs have influenced clinical adoption pathways by altering the relative price of premium intraocular lenses, femtosecond laser modules, and high-end phacoemulsification consoles. Healthcare systems pursuing predictable budgeting placed higher value on multi-year service agreements and bundled pricing, while ambulatory centers emphasized total cost per case and consumable availability. Importantly, regulatory alignment and expedited customs processes emerged as operational levers; manufacturers that demonstrated robust compliance documentation, local warehousing, and rapid replacement capability gained competitive advantage. Looking forward, these dynamics are likely to persist unless trade policies stabilize, underscoring the need for diversified supplier relationships and transparent price modeling within procurement strategies.

Detailed segmentation insights showing how product types, technology workflows, and care settings determine adoption patterns, training needs, and procurement priorities

Critical segmentation insights reveal how product design, procedural technology, and end-user setting jointly shape adoption patterns and investment priorities in cataract surgery devices. First, examining product type shows a continuum from high-capital platforms like femtosecond laser systems to consumables and phaco consoles. Intraocular lenses occupy a central role within this spectrum and further differentiate into aspheric designs aimed at image quality optimization, extended depth of focus lenses that broaden functional vision, monofocal lenses that remain the pragmatic default, multifocal solutions intended for spectacle independence, and toric lenses that address astigmatism correction. Each subcategory imposes distinct clinical training requirements and influences postoperative patient satisfaction metrics.

Turning to technology-based segmentation, there is a clear divide between extracapsular cataract extraction methods and more contemporary approaches such as femtosecond laser assisted surgery, manual small incision techniques, and phacoemulsification. Within femtosecond-assisted workflows, procedural modules like arcuate incisions for astigmatism management, capsulotomy for consistent lens centration, and lens fragmentation for reduced phaco energy are driving complementary device purchases and procedural standardization. Finally, end-user segmentation demonstrates differentiated purchasing priorities: ambulatory surgery centers and ophthalmology clinics often prioritize throughput, instrument footprint, and consumable logistics; eye institutes focus on research-grade versatility and clinical trial readiness; hospitals emphasize breadth of service and cross-specialty integration. Together, these segmentation axes indicate that successful commercial strategies must align product modularity, training support, and service models with the unique operational realities of each care setting.

How regional reimbursement models, surgical volumes, and infrastructure differences across the Americas, Europe Middle East & Africa, and Asia-Pacific shape device strategies

Regional dynamics remain a primary determinant of device distribution strategies and commercialization approaches across the global cataract ecosystem. In the Americas, strong private payer participation combined with an extensive network of ambulatory surgery centers creates demand for devices that deliver throughput efficiency, predictable outcomes, and strong post-sale service. Conversely, institutional purchasing in the Americas often demands integrated platform compatibility and clear clinical-economic rationale to support capital investment decisions. Moving to Europe, Middle East & Africa, the region exhibits heterogenous regulatory environments and reimbursement models, with parts of Europe demonstrating rapid uptake of premium lenses and laser platforms while other markets prioritize cost-effectiveness and public procurement channels. In these territories, centralized procurement mechanisms and national clinical guidelines significantly influence adoption timelines.

Asia-Pacific presents a complex mix of high-volume cataract programs, rapidly modernizing private healthcare sectors, and regions where affordability remains the primary constraint. In several Asia-Pacific markets, the combination of high surgical volume and growing middle-class demand is spurring investment in both scalable phaco systems and premium IOL options, but suppliers must tailor service models and consumable pricing to local reimbursement realities. Across all regions, common threads include the rising importance of training ecosystems, supply chain resilience, and regulatory agility. Manufacturers that adapt regional go-to-market strategies to the local balance between cost, outcome expectations, and infrastructure capacity will be better positioned to capture diverse growth opportunities.

Competitive dynamics and strategic behaviors among platform incumbents, lens innovators, and software disruptors shaping clinical adoption and commercial advantage

Company-level dynamics in the cataract devices space are characterized by a combination of incumbent platform providers, specialized lens innovators, and agile newcomers focused on software-enabled surgical planning and consumables optimization. Incumbents that have historically delivered full-platform solutions are leveraging installed bases to upsell modular upgrades, service agreements, and training packages, thereby deepening clinical relationships and securing recurring revenue streams. At the same time, specialized intraocular lens developers are differentiating through optical engineering, premium material science, and clinical evidence that demonstrates distinct refractive advantages for targeted patient cohorts.

Newer entrants and medtech scale-ups are challenging traditional boundaries by introducing interoperable planning software, digital analytics for refractive outcomes, and supply chain innovations that reduce per-case costs. Strategic partnerships and distribution agreements remain preferred routes to accelerate market access, particularly for companies seeking to enter highly regulated markets or to expand hospital networks. Moreover, organizations that invest in robust clinical education programs and outcome registries tend to build stronger clinician advocacy and faster uptake of newer technologies. Ultimately, competitive advantage accrues to companies that align product innovation with demonstrable clinical benefit, flexible commercial models, and proven post-sale support.

Practical strategic recommendations to accelerate technology adoption, secure procurement advantage, and enhance supply chain and clinical support capabilities

For industry leaders seeking to translate intelligence into impact, a set of actionable recommendations can expedite clinical adoption, strengthen supply chain resilience, and optimize commercial positioning. First, align product development with validated clinical needs by prioritizing features that reduce intraoperative variability, improve patient-reported outcomes, and integrate into existing surgical workflows. By doing so, manufacturers will make the value proposition clearer to both surgeons and procurement committees. Second, develop flexible pricing and service models that accommodate the distinct economics of ambulatory surgery centers, hospitals, and specialty clinics, recognizing that total cost per case and consumable logistics are frequently decisive in purchase decisions.

Additionally, mitigate trade and regulatory risk by diversifying supplier networks and establishing localized inventory buffers in high-demand regions. Investing in clinician education and comprehensive outcome tracking provides a dual benefit: it accelerates evidence generation needed for premium device adoption and strengthens post-market surveillance. Finally, pursue interoperability through open standards for surgical planning and documentation, which will enhance compatibility with hospital IT systems and reduce barriers to adoption. Taken together, these steps create a practical roadmap for improving market receptivity while reducing operational friction for both providers and manufacturers.

Methodological framework combining primary clinician and procurement engagement with secondary evidence synthesis and rigorous cross-validation procedures

The research methodology underpinning this report combines systematic primary engagement with secondary evidence synthesis to ensure robust, actionable insights. Primary methods included structured interviews with practicing ophthalmic surgeons, procurement leaders across hospitals and ambulatory centers, and device engineers responsible for platform integration. These engagements were complemented by site visits to high-volume surgical centers and consultations with regulatory specialists to verify device clearances and post-market requirements. Data from these sources were triangulated with peer-reviewed literature, clinical outcome registries, and device labeling to validate technical claims and performance differentials.

Analytical approaches encompassed qualitative thematic analysis of clinician priorities, supplier capability mapping, and scenario assessments to explore sensitivity to trade policy shifts and reimbursement changes. Quality assurance steps included cross-validation of interview findings, review of methodology by clinical advisors, and iterative refinement of assumptions through stakeholder feedback. Together, these methods produced a balanced view that integrates clinical judgment, operational realities, and regulatory context, enabling readers to derive practical implications for procurement, product development, and market entry strategies.

Integrating clinical innovation, operational adaptability, and supply chain resilience to secure sustainable adoption and competitive positioning in cataract therapy

In closing, cataract surgery devices are at an inflection point where technological innovation, care delivery decentralization, and geopolitical factors collectively influence clinical practice and commercial strategy. Precision lasers, advanced intraocular lens optics, and digital surgical planning are expanding the set of achievable patient outcomes, while shifts toward ambulatory settings elevate the importance of throughput, device compatibility, and consumable logistics. Concurrently, trade policy developments have underscored the vulnerability of global supply chains and the strategic value of localized manufacturing and flexible procurement arrangements.

Therefore, stakeholders who invest in evidence-based product differentiation, robust clinician education, and resilient supply ecosystems will be better equipped to navigate uncertainty and capitalize on opportunities. By synthesizing clinical priorities with operational constraints and regulatory considerations, decision-makers can craft strategies that promote sustainable adoption, improve patient outcomes, and strengthen competitive positioning in a rapidly evolving landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cataract Surgery Devices Market, by Product Type

  • 8.1. Femtosecond Laser Systems
  • 8.2. Intraocular Lenses
    • 8.2.1. Aspheric Iols
    • 8.2.2. Extended Depth Of Focus Iols
    • 8.2.3. Monofocal Iols
    • 8.2.4. Multifocal Iols
    • 8.2.5. Toric Iols
  • 8.3. Ocular Viscoelastic Devices
  • 8.4. Phacoemulsification Equipment
  • 8.5. Surgical Consumables

9. Cataract Surgery Devices Market, by Technology

  • 9.1. Extracapsular Cataract Extraction
  • 9.2. Femtosecond Laser Assisted
    • 9.2.1. Arcuate Incisions
    • 9.2.2. Capsulotomy
    • 9.2.3. Lens Fragmentation
  • 9.3. Manual Small Incision
  • 9.4. Phacoemulsification

10. Cataract Surgery Devices Market, by End User

  • 10.1. Ambulatory Surgery Centers
  • 10.2. Eye Institutes
  • 10.3. Hospitals
  • 10.4. Ophthalmology Clinics

11. Cataract Surgery Devices Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Cataract Surgery Devices Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Cataract Surgery Devices Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Cataract Surgery Devices Market

15. China Cataract Surgery Devices Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. Abbott Laboratories
  • 16.6. Alcon, Inc.
  • 16.7. Bausch & Lomb Incorporated
  • 16.8. Carl Zeiss Meditec AG
  • 16.9. Essilor International S.A.
  • 16.10. HAAG-Streit Holding AG
  • 16.11. HOYA Surgical Optics, Inc.
  • 16.12. Johnson & Johnson Vision Care, Inc.
  • 16.13. Lenstec, Inc.
  • 16.14. NIDEK Co., Ltd.
  • 16.15. PhysIOL SA
  • 16.16. Rayner Intraocular Lenses Limited
  • 16.17. STAAR Surgical Company
  • 16.18. Topcon Corporation
  • 16.19. Ziemer Ophthalmic Systems AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CATARACT SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CATARACT SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES CATARACT SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA CATARACT SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ASPHERIC IOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ASPHERIC IOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ASPHERIC IOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTENDED DEPTH OF FOCUS IOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTENDED DEPTH OF FOCUS IOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTENDED DEPTH OF FOCUS IOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MONOFOCAL IOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MONOFOCAL IOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MONOFOCAL IOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MULTIFOCAL IOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MULTIFOCAL IOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MULTIFOCAL IOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TORIC IOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TORIC IOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TORIC IOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OCULAR VISCOELASTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OCULAR VISCOELASTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OCULAR VISCOELASTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY SURGICAL CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY SURGICAL CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY SURGICAL CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTRACAPSULAR CATARACT EXTRACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTRACAPSULAR CATARACT EXTRACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTRACAPSULAR CATARACT EXTRACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ARCUATE INCISIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ARCUATE INCISIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ARCUATE INCISIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY CAPSULOTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY CAPSULOTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY CAPSULOTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY LENS FRAGMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY LENS FRAGMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY LENS FRAGMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MANUAL SMALL INCISION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MANUAL SMALL INCISION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MANUAL SMALL INCISION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EYE INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EYE INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EYE INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 129. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 131. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 147. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 149. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. NATO CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. NATO CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. NATO CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 153. NATO CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. NATO CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 155. NATO CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES CATARACT SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. CHINA CATARACT SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. CHINA CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 166. CHINA CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 168. CHINA CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)